Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Alison R Zoller

2PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jun 26, 2026
Reply to "Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer".

|Mar 12, 2026
A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer.

Gayle S Jameson, Denise J Roe, Erkut Borazanci

Pageof 1

Frequent Collaborators

2 joint publications

Gayle S Jameson

2 joint publications

Diana L Hanna

1 joint publications

J Erin Wiedmeier-Nutor

1 joint publications

Keehoon Lee

1 joint publications

Derek Cridebring

Frequent Collaborators

2 joint publications

Gayle S Jameson

2 joint publications

Diana L Hanna

1 joint publications

J Erin Wiedmeier-Nutor

1 joint publications

Keehoon Lee